193 related articles for article (PubMed ID: 38166643)
1. Prognostic significance of 18F-Fluorodeoxyglucose positron-emission tomography parameters in patients with biliary tract cancers: a meta-analysis.
Zheng X; Shi Y; Kulabieke D; Wang Z; Cheng Y; Qian J
BMC Med Imaging; 2024 Jan; 24(1):9. PubMed ID: 38166643
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F
PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
Hong JH; Min KJ; Lee JK; So KA; Jung US; Kim S; Eo JS
Medicine (Baltimore); 2016 Mar; 95(9):e2992. PubMed ID: 26945420
[TBL] [Abstract][Full Text] [Related]
4. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer.
Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E
Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of 18F-FDG PET/CT in malignant pleural mesothelioma: a meta-analysis.
Wang Y; Xu Y; Kan Y; Wang W; Yang J
Acta Radiol; 2023 Feb; 64(2):552-562. PubMed ID: 35315714
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma: A systematic review and meta-analysis.
Zhu D; Wang L; Zhang H; Chen J; Wang Y; Byanju S; Liao M
Medicine (Baltimore); 2017 Aug; 96(33):e7813. PubMed ID: 28816978
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
Liu J; Dong M; Sun X; Li W; Xing L; Yu J
PLoS One; 2016; 11(1):e0146195. PubMed ID: 26727114
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer.
Im HJ; Oo S; Jung W; Jang JY; Kim SW; Cheon GJ; Kang KW; Chung JK; Kim EE; Lee DS
Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707
[TBL] [Abstract][Full Text] [Related]
9.
Mi L; Zhao Y; Zhao X; Yin F; Yin X; Li N; Shi J; Han X; Duan X; Zhao M; Han G; Wang J
Cancer Biother Radiopharm; 2021 Oct; 36(8):662-671. PubMed ID: 32783634
[No Abstract] [Full Text] [Related]
10. Metabolic parameters of [
Markus M; Sartor H; Bjurberg M; Trägårdh E
Acta Oncol; 2023 Feb; 62(2):180-188. PubMed ID: 36815676
[TBL] [Abstract][Full Text] [Related]
11. Prognostic prediction by
Hu R; Zhang Y; Liu S; Lee P; Liu C; Liu A
Front Oncol; 2023; 13():1208531. PubMed ID: 37519817
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: A meta-analysis.
Jin A; Lin X; Yin X; Cui Y; Ma L
Medicine (Baltimore); 2022 Sep; 101(39):e30798. PubMed ID: 36181127
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of baseline
Xia L; Li X; Zhu J; Gao Z; Zhang J; Yang G; Wang Z
Radiat Oncol; 2023 Feb; 18(1):41. PubMed ID: 36829219
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of
Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents.
Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ
Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of metabolic tumour volume and total lesion glycolysis measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in small cell lung cancer: A systematic review and meta-analysis.
Nie K; Zhang YX; Nie W; Zhu L; Chen YN; Xiao YX; Liu SY; Yu H
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):84-93. PubMed ID: 30230710
[TBL] [Abstract][Full Text] [Related]
17. Early Metabolic Response Assessed Using 18F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer.
Kim N; Park W; Cho WK; Bae DS; Kim BG; Lee JW; Kim TJ; Choi CH; Lee YY; Cho YS
Cancer Res Treat; 2021 Jul; 53(3):803-812. PubMed ID: 33321566
[TBL] [Abstract][Full Text] [Related]
18. High Metabolic Tumour Volume on 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Poor Survival from Neuroendocrine Neoplasms.
Chan DL; Bernard EJ; Schembri G; Roach PJ; Johnson M; Pavlakis N; Clarke S; Bailey DL
Neuroendocrinology; 2020; 110(11-12):950-958. PubMed ID: 31711058
[TBL] [Abstract][Full Text] [Related]
19. The correlation of
Qu YH; Long N; Ran C; Sun J
Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540
[TBL] [Abstract][Full Text] [Related]
20. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma.
Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
